Ethena Labs Reaches Agreement with BaFin to Wind Down USDe Stablecoin in EU via 42-Day Redemption Plan

25.06.2025 23:00

Ethena Labs, a key decentralized finance player, has secured a critical agreement with Germany's financial regulator, BaFin, to implement a 42-day redemption plan for its USDe stablecoin holders within the European Union (EU) and European Economic Area (EEA).

The deal marks the end of a months-long regulatory standoff wherein BaFin had accused Ethena's German subsidiary, Ethena GmbH, of offering unregistered securities and violating EU regulations related to the Markets in Crypto-Assets Regulation (MiCA). The regulator ordered a halt on public USDe offerings, froze related assets, and demanded the suspension of services within the EU.

Starting June 25, 2025, USDe holders in the EU/EEA have a 42-day window ending August 6, 2025, to redeem their tokens through Ethena GmbH. After this deadline, Ethena GmbH will cease operations in the region, and any future claims must be handled by Ethena's offshore entity, Ethena (BVI) Ltd., based in the British Virgin Islands.

This resolution represents a significant precedent in the global crypto regulatory landscape, demonstrating the increasing application of existing securities laws to novel stablecoin structures — particularly synthetic stablecoins like USDe, which differ from traditional fiat-backed coins due to backing by crypto assets and short perpetual positions.

The agreement underscores the importance for crypto projects to proactively engage with regulators, maintain transparent operations, and flexibly adapt business models to comply with fragmented jurisdictional frameworks. The successful wind-down also reflects the growing emphasis on consumer protection and investor safeguards.

Ethena Labs’ exit from the EU stablecoin market highlights the tightening regulatory grip under MiCA, which became fully applicable in 2024, prompting multiple platforms to delist non-compliant stablecoins. As such, this case offers insights into how stablecoin issuers might navigate the evolving balance between innovation and regulatory compliance moving forward.